Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topoisomerase I inhibitors: topotecan and irenotecan.

× No keyword cloud information.

37 in total

Review 1. Camptothecin delivery methods.

Authors: A Hatefi; B Amsden
Journal: Pharm Res Date: 2002-10 Impact factor: 4.200

2. Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptor.

Authors: Yakun Chen; Yong Tang; Gregory T Robbins; Daotai Nie
Journal: J Pharmacol Exp Ther Date: 2010-05-26 Impact factor: 4.030

3. Salvage therapy with topotecan in heavily pretreated ovarian cancer patients.

Authors: Lubomir Bodnar; Gabriel Wcislo; Anna Nasilowska; Katarzyna Szarlej-Wcislo; Agnieszka Gasowska-Bodnar; Marta Smoter; Cezary Szczylik
Journal: J Cancer Res Clin Oncol Date: 2008-11-26 Impact factor: 4.553

4. Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.

Authors: Jessica K Roberts; Anna V Birg; Tong Lin; Vinay M Daryani; John C Panetta; Alberto Broniscer; Giles W Robinson; Amar J Gajjar; Clinton F Stewart
Journal: Drug Metab Dispos Date: 2016-04-06 Impact factor: 3.922

5. Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

Authors: Srinevas K Reddy; Colleen Reilly; Min Zhan; Ayse L Mindikoglu; Yixing Jiang; Barton F Lane; H Richard Alexander; William J Culpepper; Samer S El-Kamary
Journal: Med Oncol Date: 2014-05-06 Impact factor: 3.064

6. Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer.

Authors: In Ja Park; Hee Cheol Kim; Chang Sik Yu; Heung Moon Chang; Jea Hwan Lee; Jong Hoon Kim; Tae Won Kim; Jung Sun Kim; Jin Cheon Kim
Journal: Cancer Res Treat Date: 2004-12-31 Impact factor: 4.679

7. Effect of irinotecan on the tongue mucosa of juvenile male albino rat at adulthood.

Authors: Marwa Awad Abdel Hamid Ibrahim; Walaa M Elwan
Journal: Int J Exp Pathol Date: 2019-10-02 Impact factor: 1.925

8. Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.

Authors: Sung Yong Oh; Hyun Jin Kim; Tae Hyo Kim; Gyeong-Won Lee; Hoon Gu Kim; Chi-Young Jeong; Hyuk-Chan Kwon; Jung Hun Kang
Journal: Invest New Drugs Date: 2009-05-15 Impact factor: 3.850

Review 9. Experience with irinotecan for the treatment of malignant glioma.

Authors: James J Vredenburgh; Annick Desjardins; David A Reardon; Henry S Friedman
Journal: Neuro Oncol Date: 2008-09-10 Impact factor: 12.300

Review 10. Clinical pharmacokinetics of topotecan.

Authors: V M Herben; W W ten Bokkel Huinink; J H Beijnen
Journal: Clin Pharmacokinet Date: 1996-08 Impact factor: 6.447